NASDAQ: TCRT - Alaunos Therapeutics, Inc.

Yield per half year: -70.07%
Sector: Healthcare

Alaunos Therapeutics, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
4.35 48.77 -91.08% 2.25 +93.48%
P/S 23752.94 33.76 70263.5%
P/BV 18.83 4.82 290.62%
P/FCF -0.9789 61 -101.6%
Ev/Ebitda -4.31 -22.15 -80.56%
Ev/S 22540.54 22.56 99795.94%
Ev/FCF -3.71 68.78 -105.4%
E/P -1.18 0.0178 -6739.03%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-523560 4.98 -10519819.05% -131204.63 +299.04%
ROE -557.16 9.61 -5896.74%
ROA -425.27 0.3443 -123631.62%
ROIC -69 7.63 -1003.81%
ROS -702800 -25.17 2792100.11%
ROCE -451.77 15.35 -3043.05%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.7449 -3.68 -79.73% -0.4835 +54.08%
Nеt Debt/Ebitda 0.2316 -3.44 -106.74%
Debt/Ratio 2.36 0.1985 1088.98%
Debt/Equity 2.29 1.66 38.01%
Debt/Net Income -0.5549 10.32 -105.38%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5442 -100% 0 0%
Number of years of dividend growth 0 0.2632 -100%
DSI 0 0.2193 -100%
Average dividend growth 0 0.4414 -100%
Average percentage for 5 years 0 0.4968 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5442

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-99.92 -56.89 75.64%
Growth impulse Ebitda in 5 years -977.46 -54.68 1687.6%
Growth impulse Net Income in 5 years -70.22 -58.33 20.38%
Growth impulse FCF in 5 years -26 -49.48 -47.45%
Growth impulse EPS in 5 years 3038.43 -32.41 -9474.98%
IP Score
2.91/10

Similar companies

Illumina

Amarin

DENTSPLY SIRONA

ImmunoGen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription